BOLDEN

BOLDEN African News · Wednesday 18 November 2026

MoroccoHealthcare and life sciences

Laprophan's Casablanca share offer draws MAD 15.3 billion of demand, about seven times its size

Moroccan pharmaceutical group Laprophan's IPO of up to MAD 2.22 billion drew total demand of MAD 15.3 billion from more than 44,000 subscribers, according to provisional figures from the book-building syndicate. The offer combined 4,105,500 new shares with 2,412,200 existing shares at MAD 341 a share, and nearly 90% of the capital increase is earmarked for buying 100% of Corporate Investment Holding, parent of the Polymedic laboratory. First listing on the Casablanca Stock Exchange under the symbol LPH is scheduled for 25 November.

Why it matters

The proceeds fund an acquisition that enlarges a Moroccan drug manufacturer, and the demand shows strong investor appetite for Casablanca listings.

Sources: Le360, La Vie éco · 18 November 2026

← All news